BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8364 related articles for article (PubMed ID: 1676603)

  • 1. Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression.
    Knight CR; Rees RC; Griffin M
    Biochim Biophys Acta; 1991 Jun; 1096(4):312-8. PubMed ID: 1676603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The existence of an inactive form of transglutaminase within metastasising tumours.
    Knight CR; Rees RC; Elliott BM; Griffin M
    Biochim Biophys Acta; 1990 Jun; 1053(1):13-20. PubMed ID: 1973055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis.
    Knight RL; Hand D; Piacentini M; Griffin M
    Eur J Cell Biol; 1993 Feb; 60(1):210-6. PubMed ID: 8096461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth.
    Johnson TS; Knight CR; el-Alaoui S; Mian S; Rees RC; Gentile V; Davies PJ; Griffin M
    Oncogene; 1994 Oct; 9(10):2935-42. PubMed ID: 7916148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis).
    el Alaoui S; Mian S; Lawry J; Quash G; Griffin M
    FEBS Lett; 1992 Oct; 311(2):174-8. PubMed ID: 1356831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas.
    Johnson TS; Scholfield CI; Parry J; Griffin M
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):105-12. PubMed ID: 9512467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.
    Johnson TS; Griffin M; Thomas GL; Skill J; Cox A; Yang B; Nicholas B; Birckbichler PJ; Muchaneta-Kubara C; Meguid El Nahas A
    J Clin Invest; 1997 Jun; 99(12):2950-60. PubMed ID: 9185519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of DNA content and nuclear pleomorphism in metastatic variants of the B16 murine melanoma and hamster lymphoma and its liver metastasis using image analysis techniques.
    Lakshmi MS; Sherbet GV
    Clin Exp Metastasis; 1990; 8(6):553-66. PubMed ID: 2225569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and activation of tissue transglutaminase during programmed cell death.
    Fesus L; Thomazy V; Falus A
    FEBS Lett; 1987 Nov; 224(1):104-8. PubMed ID: 2890537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis.
    Hand D; Elliott BM; Griffin M
    Biochim Biophys Acta; 1988 Jun; 970(2):137-45. PubMed ID: 2898262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines.
    van Groningen JJ; Klink SL; Bloemers HP; Swart GW
    Int J Cancer; 1995 Jan; 60(3):383-7. PubMed ID: 7829248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis by transforming growth factor-beta 1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression.
    Fukuda K; Kojiro M; Chiu JF
    Hepatology; 1993 Oct; 18(4):945-53. PubMed ID: 7691707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a cytosolic transglutaminase from a cultured human tumour-cell line.
    Dadabay CY; Pike LJ
    Biochem J; 1989 Dec; 264(3):679-85. PubMed ID: 2575900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue transglutaminase and the progression of human renal scarring.
    Johnson TS; El-Koraie AF; Skill NJ; Baddour NM; El Nahas AM; Njloma M; Adam AG; Griffin M
    J Am Soc Nephrol; 2003 Aug; 14(8):2052-62. PubMed ID: 12874459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positive association between agonist-induced cyclic AMP production in vitro and metastatic potential in murine B16 melanoma and hamster fibrosarcoma.
    Hill SE; Rees RC; MacNeil S
    Clin Exp Metastasis; 1990; 8(5):461-74. PubMed ID: 2167781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis).
    Piacentini M; Fesus L; Farrace MG; Ghibelli L; Piredda L; Melino G
    Eur J Cell Biol; 1991 Apr; 54(2):246-54. PubMed ID: 1679009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-actin is a target for transglutaminase activity at synaptic endings in chicken telencephalic cell cultures.
    Dolge L; Aufenvenne K; Traupe H; Baumgartner W
    J Mol Neurosci; 2012 Feb; 46(2):410-9. PubMed ID: 21789544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic heterogeneity in a spontaneously metastatic HSV-2 induced hamster fibrosarcoma: association of phenotypic and genotypic properties with metastatic potential.
    Teale DM; Rees RC
    Invasion Metastasis; 1987; 7(3):129-43. PubMed ID: 3036738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the epsilon-(gamma-glutamyl)lysine bonds formed by transglutaminase activity.
    Johnson GV; LeShoure R
    J Neurosci Methods; 2004 Apr; 134(2):151-8. PubMed ID: 15003381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Tissue" transglutaminase in animal development.
    Piacentini M; Rodolfo C; Farrace MG; Autuori F
    Int J Dev Biol; 2000; 44(6):655-62. PubMed ID: 11061429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 419.